| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines addressing unmet medical needs in the United States, Europe, and other internatio..
>Volltext.. |
| 151495.13 Mio. EUR |
| 164849.33 Mio. EUR |
| 25434.55 Mio. EUR |
| 12576.49 Mio. EUR |
| 7350.18 Mio. EUR |
| 5.91 EUR |
| 22060.04 Mio. EUR |
| 6533.11 Mio. EUR |
| 8653.52 Mio. EUR |
| 0.81 |
| -9.65% |
| 1462.66% |
| 2.03 EUR |
| 2.24% |
| 2.32% |
| 15.12.25 - 0.671895€ 15.09.25 - 0.67782€ >weitere anzeigen... |
| GILEAD, REMDESIVIR |
| 19.03.26 |
|